Omega Diagnostics Group PLC reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was GBP 7.55 million compared to GBP 8.54 million a year ago. Net loss was GBP 3.86 million compared to GBP 11.33 million a year ago.

Basic loss per share from continuing operations was GBP 0.014 compared to GBP 0.009 a year ago. Diluted loss per share from continuing operations was GBP 0.014 compared to GBP 0.009 a year ago. Basic loss per share was GBP 0.017 compared to GBP 0.062 a year ago.

Diluted loss per share was GBP 0.017 compared to GBP 0.062 a year ago.